Stock listing

NASDAQ:GEVA Synageva BioPharma Corp Stock

Follow Synageva BioPharma Corp into a list and get an email when it puts out news.

Last close · NASDAQ:GEVA

$238.60 USD

Close on Jun 22, 2015 · No longer trades

Jan 4, 1999 to last close +751.1% · monthly closes, Jan 4, 1999 – Jun 22, 2015
Lowest – highest close
$4.30 – $238.60 USDSince Jan 4, 1999 · lowest Jan 20, 2009 · highest Jun 22, 2015

Delisted NASDAQ:GEVA no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:GEVA
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Synageva BioPharma Corp on 6ix

Decks
6 decks · latest Jun 5, 2015

Decks

DeckKindSlidesDate
Merger or Acquisition (June 2015)Merger or acquisition31 slidesJun 5, 2015
Merger or Acquisition (May 2015)Merger or acquisition30 slidesMay 11, 2015
Merger or Acquisition (May 2015)Merger or acquisition20 slidesMay 6, 2015
Trimeris — Merger or Acquisition (September 2011)Merger or acquisition32 slidesSep 7, 2011
Trimeris — Merger or Acquisition (July 2011)Merger or acquisition19 slidesJul 27, 2011
Trimeris — Merger or Acquisition (July 2011)Merger or acquisition32 slidesJul 20, 2011

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Mark Alan Goldberg
Other companies: Blueprint Medicines Corp (Director · Since at least Jun 25, 2015); Audentes Therapeutics Inc (Director · Dec 11, 2017 – Jan 15, 2020 · Past); aTyr Pharma, Inc. (Director · May 6, 2015 – May 9, 2017 · Past); Crescent Biopharma, Inc. (Director · Jul 8, 2014 – May 1, 2024 · Past); Aceragen Inc. (Director · Jan 7, 2014 – Jun 23, 2022 · Past); ImmunoGen Inc (Director · Nov 8, 2011 – Feb 12, 2024 · Past)
EVP, Medical & Reg. Strategy · Nov 2, 2011 – Sep 19, 2014 · Past
Glen WilliamsSVP, Technical Operations · Sep 24, 2012 – Jun 22, 2015 · Past

Open People

Log in to ask 6ix AI your own questions about Synageva BioPharma Corp.